{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:07:27Z","timestamp":1790892447284,"version":"4.1.0"},"reference-count":251,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Diagnosing inflammatory bowel disease (IBD) can often be challenging, and differentiating between Crohn\u2019s disease and ulcerative colitis can be particularly difficult. Diagnostic procedures for IBD include laboratory tests, endoscopy, pathological tests, and imaging tests. Serological and stool tests can be easily performed in an outpatient setting and provide critical diagnostic clues. Although endoscopy is an invasive procedure, it offers essential diagnostic information and allows for tissue biopsy and therapeutic procedures. Video capsule endoscopy and device-assisted enteroscopy are endoscopic procedures used to evaluate the small bowel. In addition to endoscopy, magnetic resonance imaging, computed tomography, and ultrasound (US) are valuable tools for small bowel assessment. Among these, US is noninvasive and easily utilized, making its use highly practical in daily clinical practice. Endoscopic biopsy aids in the diagnosis of IBD and is crucial for assessing the histological activity of the disease, facilitating a thorough evaluation of disease remission, and aiding in the development of treatment strategies. Recent advances in artificial intelligence hold promise for enhancing various aspects of IBD management, including diagnosis, monitoring, and precision medicine. This review compiles current procedures and promising future tools for the diagnosis of IBD, providing comprehensive insights.<\/jats:p>","DOI":"10.3390\/diagnostics14131384","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T03:38:27Z","timestamp":1719805107000},"page":"1384","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Diagnostic Procedures for Inflammatory Bowel Disease: Laboratory, Endoscopy, Pathology, Imaging, and Beyond"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6393-0809","authenticated-orcid":false,"given":"Seung Min","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-9475","authenticated-orcid":false,"given":"Dong Hoon","family":"Baek","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e065186","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: A systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"ref_2","unstructured":"Korean Association for the Study of Intestinal Diseases (2020). 2020 Inflammatory Bowel Disease Fact Sheet in Korea, Korean Association for the Study of Intestinal Diseases. Available online: http:\/\/m.kasid.org\/file\/IBM\/IBD%20fact%20sheet_1217.pdf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med. Life"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Perler, B.K., Ungaro, R., Baird, G., Mallette, M., Bright, R., Shah, S., Shapiro, J., and Sands, B.E. (2019). Presenting symptoms in inflammatory bowel disease: Descriptive analysis of a community-based inception cohort. BMC Gastroenterol., 19.","DOI":"10.1186\/s12876-019-0963-7"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Laredo, V., Garcia-Mateo, S., Martinez-Dominguez, S.J., Lopez de la Cruz, J., Gargallo-Puyuelo, C.J., and Gomollon, F. (2023). Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management. Cancers, 15.","DOI":"10.3390\/cancers15030871"},{"key":"ref_7","first-page":"e17187","article-title":"Extra-Intestinal Manifestations of Inflammatory Bowel Disease","volume":"13","author":"Sange","year":"2021","journal-title":"Cureus"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/ecco-jcc\/jjac037","article-title":"Mental Health, Work Presenteeism, and Exercise in Inflammatory Bowel Disease","volume":"16","author":"Sciberras","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.3748\/wjg.v25.i38.5862","article-title":"Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil","volume":"25","author":"Parra","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_10","first-page":"614","article-title":"The Manitoba Inflammatory Bowel Disease Cohort Study: Prolonged symptoms before diagnosis\u2014How much is irritable bowel syndrome?","volume":"4","author":"Burgmann","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1586\/17474124.2015.1025054","article-title":"Seasonal clustering in inflammatory bowel disease: A single centre experience","volume":"9","author":"Basaranoglu","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12664-022-01303-x","article-title":"Diagnostic delay in adult inflammatory bowel disease: A systematic review","volume":"42","author":"Cross","year":"2023","journal-title":"Indian J. Gastroenterol. Off. J. Indian Soc. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.2147\/JIR.S268262","article-title":"Indeterminate Colitis\u2014Update on Treatment Options","volume":"14","author":"Venkateswaran","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.3748\/wjg.v23.i35.6474","article-title":"Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery","volume":"23","author":"Lee","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MEG.0000000000000244","article-title":"Delayed diagnosis is influenced by the clinical pattern of Crohn\u2019s disease and affects treatment outcomes and quality of life in the long term: A cross-sectional study of 361 patients in Southern Italy","volume":"27","author":"Pellino","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S1807-59322010000200015","article-title":"Noninvasive methods in evaluation of inflammatory bowel disease: Where do we stand now? An update","volume":"65","author":"Turkay","year":"2010","journal-title":"Clinics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"710915","DOI":"10.1155\/2014\/710915","article-title":"Biomarkers of inflammatory bowel disease","volume":"2014","author":"Fengming","year":"2014","journal-title":"Dis. Markers"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1097\/MIB.0000000000000135","article-title":"Role of biomarkers in the study and management of inflammatory bowel disease: A \u201cnonsystematic\u201d review","volume":"20","author":"Sachar","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gut.35.1.77","article-title":"Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease","volume":"35","author":"Mazlam","year":"1994","journal-title":"Gut"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1469-1809.2006.00272.x","article-title":"Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia","volume":"70","author":"Chasman","year":"2006","journal-title":"Ann. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00042737-200204000-00013","article-title":"A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders","volume":"14","author":"Poullis","year":"2002","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_24","first-page":"69","article-title":"Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic","volume":"89","author":"Davies","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13223-020-00433-1","article-title":"Assessment of clinical activity and severity using serum ANCA and ASCA antibodies in patients with ulcerative colitis","volume":"16","author":"Pang","year":"2020","journal-title":"Allergy Asthma Clin. Immunol. Off. J. Can. Soc. Allergy Clin. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0171-2985(11)80509-7","article-title":"A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn\u2019s disease","volume":"181","author":"Rump","year":"1990","journal-title":"Immunobiology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1155\/2011\/712350","article-title":"Assessing inflammatory bowel disease-associated antibodies in Caucasian and First Nations cohorts","volume":"25","author":"Bernstein","year":"2011","journal-title":"Can. J. Gastroenterol. J. Can. De Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","article-title":"Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"101","author":"Reese","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3892\/br.2017.860","article-title":"Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotype","volume":"6","author":"Wang","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.34172\/mejdd.2022.286","article-title":"The Correlation between New Serological Markers and Disease Phenotype and Activation in Inflammatory Bowel Disease","volume":"14","author":"Yorulmaz","year":"2022","journal-title":"Middle East J. Dig. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/j.1572-0241.2002.05689.x","article-title":"Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn\u2019s disease","volume":"97","author":"Esters","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000515361","article-title":"Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-alpha Agents in Patients with Ulcerative Colitis","volume":"6","author":"Yoshida","year":"2021","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.pathol.2019.07.002","article-title":"The significance of ANCA positivity in patients with inflammatory bowel disease","volume":"51","author":"Lee","year":"2019","journal-title":"Pathology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/ibd.22862","article-title":"Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: A systematic review and meta-analysis","volume":"18","author":"Kaul","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gut.47.4.487","article-title":"Marker antibody expression stratifies Crohn\u2019s disease into immunologically homogeneous subgroups with distinct clinical characteristics","volume":"47","author":"Vasiliauskas","year":"2000","journal-title":"Gut"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s005350300020","article-title":"Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: Diagnostic accuracy and clinical value","volume":"38","author":"Hisabe","year":"2003","journal-title":"J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jped.2023.10.005","article-title":"Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease","volume":"100","author":"Kim","year":"2024","journal-title":"J. Pediatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1590\/s0004-2803.202100000-89","article-title":"Classical Serological Markers in Pediatric Inflammatory Bowel Disease in Brazil","volume":"58","author":"Rodrigues","year":"2021","journal-title":"Arq. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3748\/wjg.v22.i3.1304","article-title":"Antibody markers in the diagnosis of inflammatory bowel disease","volume":"22","author":"Mitsuyama","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_40","first-page":"232","article-title":"Serum anti-glycan antibodies in paediatric-onset Crohn\u2019s disease: Association with disease phenotype and diagnostic accuracy","volume":"9","author":"Sladek","year":"2014","journal-title":"Prz. Gastroenterol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Jiang, M., Zeng, Z., Chen, K., Dang, Y., Li, L., Ma, C., Cheng, R., Hu, K., Li, X., and Zhang, H. (2022). Enterogenous Microbiotic Markers in the Differential Diagnosis of Crohn\u2019s Disease and Intestinal Tuberculosis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.820891"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2020.07.065","article-title":"Predicting Outcomes in Pediatric Crohn\u2019s Disease for Management Optimization: Systematic Review and Consensus Statements from the Pediatric Inflammatory Bowel Disease-Ahead Program","volume":"160","author":"Ricciuto","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14740\/jocmr4016","article-title":"Association Between Serological Markers and Crohn\u2019s Disease Activity","volume":"12","author":"Ahmed","year":"2020","journal-title":"J. Clin. Med. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mucimm.2023.11.001","article-title":"Intestinal damage is required for the pro-inflammatory differentiation of commensal CBir1-specific T cells","volume":"17","author":"Sorini","year":"2024","journal-title":"Mucosal Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1053\/j.gastro.2021.03.064","article-title":"Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn\u2019s Disease","volume":"161","author":"Alexander","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","article-title":"Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn\u2019s disease","volume":"128","author":"Targan","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"G403","DOI":"10.1152\/ajpgi.00357.2004","article-title":"Elevated flagellin-specific immunoglobulins in Crohn\u2019s disease","volume":"288","author":"Sitaraman","year":"2005","journal-title":"Am. J. Physiology. Gastrointest. Liver Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","article-title":"Bacterial flagellin is a dominant antigen in Crohn disease","volume":"113","author":"Lodes","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/jgh.13677","article-title":"Serologic antibodies in relation to outcome in postoperative Crohn\u2019s disease","volume":"32","author":"Hamilton","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000442934","article-title":"ASCA, ANCA, ALCA and Many More: Are They Useful in the Diagnosis of Inflammatory Bowel Disease?","volume":"34","author":"Zhou","year":"2016","journal-title":"Dig. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/MIB.0b013e318281f2a1","article-title":"Serum antibodies associated with complex inflammatory bowel disease","volume":"19","author":"Elkadri","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_52","first-page":"817","article-title":"Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn\u2019s Disease: A Systematic Review","volume":"20","author":"Steiner","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/gast.2000.8519","article-title":"Identification of a novel bacterial sequence associated with Crohn\u2019s disease","volume":"119","author":"Sutton","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e11772","DOI":"10.1097\/MD.0000000000011772","article-title":"Diagnostic utility of serological biomarkers in patients with Crohn\u2019s disease: A case-control study","volume":"97","author":"Yao","year":"2018","journal-title":"Medicine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Xiao, X., Mao, X., Chen, D., Yu, B., He, J., Yan, H., and Wang, J. (2022). miRNAs Can Affect Intestinal Epithelial Barrier in Inflammatory Bowel Disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.868229"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"James, J.P., Riis, L.B., Malham, M., Hogdall, E., Langholz, E., and Nielsen, B.S. (2020). MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217893"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Sarshar, M., Scribano, D., Ambrosi, C., Palamara, A.T., and Masotti, A. (2020). Fecal microRNAs as Innovative Biomarkers of Intestinal Diseases and Effective Players in Host-Microbiome Interactions. Cancers, 12.","DOI":"10.3390\/cancers12082174"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Masi, L., Capobianco, I., Magri, C., Marafini, I., Petito, V., and Scaldaferri, F. (2022). MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147991"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3000605221089503","DOI":"10.1177\/03000605221089503","article-title":"MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: A systematic review and meta-analysis","volume":"50","author":"Sun","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1053\/j.gastro.2008.07.068","article-title":"MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha","volume":"135","author":"Wu","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ibd.21450","article-title":"Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn\u2019s disease","volume":"17","author":"Wu","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e00134","DOI":"10.14309\/ctg.0000000000000134","article-title":"MicroRNA-320a Monitors Intestinal Disease Activity in Patients with Inflammatory Bowel Disease","volume":"11","author":"Cordes","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.15159","article-title":"Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease","volume":"49","author":"Chen","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: From biomarker to biological function","volume":"70","author":"Jukic","year":"2021","journal-title":"Gut"},{"key":"ref_66","unstructured":"Fagerhol, M.K., Dale, I., and Andersson, T. (1980, January 27\u201330). A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Proceedings of the International Symposium, Sassari, Italy."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.3748\/wjg.v18.i46.6782","article-title":"Utility of faecal calprotectin analysis in adult inflammatory bowel disease","volume":"18","author":"Smith","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/00042737-200208000-00005","article-title":"Faecal calprotectin: A marker of inflammation throughout the intestinal tract","volume":"14","author":"Summerton","year":"2002","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/00365529209011186","article-title":"Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study","volume":"27","author":"Roseth","year":"1992","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/archdischild-2018-316584","article-title":"Calprotectin instability may lead to undertreatment in children with IBD","volume":"105","author":"Haisma","year":"2020","journal-title":"Arch. Dis. Child."},{"key":"ref_71","first-page":"77","article-title":"Faecal Calprotectin","volume":"39","author":"Pathirana","year":"2018","journal-title":"Clin. Biochem. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.15324\/kjcls.2020.52.3.181","article-title":"Age-Related Fecal Calprotectin Concentrations in Healthy Adults","volume":"52","author":"Park","year":"2020","journal-title":"Korean J. Clin. Lab. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MEG.0000000000000692","article-title":"Fecal calprotectin for the prediction of small-bowel Crohn\u2019s disease by capsule endoscopy: A systematic review and meta-analysis","volume":"28","author":"Kopylov","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"732","DOI":"10.5009\/gnl20249","article-title":"Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn\u2019s Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review","volume":"15","author":"Jung","year":"2021","journal-title":"Gut Liver"},{"key":"ref_75","first-page":"191","article-title":"Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study","volume":"42","author":"Meucci","year":"2010","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1097\/MEG.0000000000001509","article-title":"Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: Meta-analysis","volume":"31","author":"Petryszyn","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/apt.17754","article-title":"Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults","volume":"58","author":"Dajti","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2015.6","article-title":"A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS","volume":"110","author":"Menees","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.MIB.0000442681.85545.31","article-title":"Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease","volume":"20","author":"Kopylov","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCG.0000000000001212","article-title":"Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis","volume":"54","author":"Dai","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_81","first-page":"12319","article-title":"Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: A meta-analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1159\/000518419","article-title":"Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn\u2019s Disease: Do They Still Have a Potential Clinical Role?","volume":"102","author":"Vernia","year":"2021","journal-title":"Digestion"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.18632\/aging.202428","article-title":"Identification of microRNA-16-5p and microRNA-21-5p in feces as potential noninvasive biomarkers for inflammatory bowel disease","volume":"13","author":"Zhou","year":"2021","journal-title":"Aging"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ecco-jcc\/jjz120","article-title":"Faecal Micro-RNAs in Inflammatory Bowel Diseases","volume":"14","author":"Verdier","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/ibd\/izy046","article-title":"Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases","volume":"24","author":"Schonauen","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_86","first-page":"295","article-title":"Diagnosis of colitis: Making the initial diagnosis","volume":"5","author":"Abreu","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.gie.2006.02.005","article-title":"ASGE guideline: Endoscopy in the diagnosis and treatment of inflammatory bowel disease","volume":"63","author":"Leighton","year":"2006","journal-title":"Gastrointest. Endosc."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/j.gastro.2004.03.023","article-title":"Endoscopy in inflammatory bowel diseases","volume":"126","author":"Hommes","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"V10","DOI":"10.1136\/gut.51.suppl_5.v10","article-title":"Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease","volume":"51","author":"Eaden","year":"2002","journal-title":"Gut"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5946\/ce.2012.45.3.254","article-title":"Differential diagnosis of inflammatory bowel disease: What is the role of colonoscopy?","volume":"45","author":"Jung","year":"2012","journal-title":"Clin. Endosc."},{"key":"ref_91","first-page":"145","article-title":"Diagnostic guideline of ulcerative colitis","volume":"53","author":"Choi","year":"2009","journal-title":"Korean J. Gastroenterol. Taehan Sohwagi Hakhoe Chi"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1155\/2014\/834512","article-title":"Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare","volume":"28","author":"Park","year":"2014","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_93","first-page":"1275","article-title":"Patchy cecal inflammation associated with distal ulcerative colitis: A prospective endoscopic study","volume":"92","author":"Geboes","year":"1997","journal-title":"Am. J. Gastroenterol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Hong, S.M., and Baek, D.H. (2023). A Review of Colonoscopy in Intestinal Diseases. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071262"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5946\/ce.2016.090","article-title":"Endoscopic Diagnosis and Differentiation of Inflammatory Bowel Disease","volume":"49","author":"Lee","year":"2016","journal-title":"Clin. Endosc."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Choudhury, A., Dhillon, J., Sekar, A., Gupta, P., Singh, H., and Sharma, V. (2023). Differentiating gastrointestinal tuberculosis and Crohn\u2019s disease\u2014A comprehensive review. BMC Gastroenterol., 23.","DOI":"10.1186\/s12876-023-02887-0"},{"key":"ref_97","first-page":"650","article-title":"Intestinal tuberculosis and Crohn\u2019s disease: The importance and difficulty of a differential diagnosis","volume":"110","year":"2018","journal-title":"Rev. Esp. Enfermedades Dig."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10620-008-0469-6","article-title":"Crohn\u2019s disease in India: A multicenter study from a country where tuberculosis is endemic","volume":"54","author":"Das","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Sudcharoen, A., Ruchikajorndech, G., Srisajjakul, S., Pongpaibul, A., Ngamskulrungroj, P., Tulyaprawat, O., and Limsrivilai, J. (2023). Clinical characteristics and diagnosis of intestinal tuberculosis in clinical practice at Thailand\u2019s largest national tertiary referral center: An 11-year retrospective review. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0282392"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/apt.16547","article-title":"Clinical features, therapeutic requirements and evolution of patients with Crohn\u2019s disease and upper gastrointestinal involvement (CROHNEX study)","volume":"54","author":"Sainz","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_101","first-page":"1546","article-title":"Upper gastrointestinal tract involvement in Crohn\u2019s disease: A relevant yet underestimated problem","volume":"53","author":"Maida","year":"2021","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0300-2977(96)00063-0","article-title":"Crohn\u2019s disease of the upper gastrointestinal tract","volume":"50","author":"Wagtmans","year":"1997","journal-title":"Neth. J. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.3748\/wjg.v24.i35.4014","article-title":"Endoscopy in inflammatory bowel disease: Role in diagnosis, management, and treatment","volume":"24","author":"Spiceland","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Sakuraba, A., Iwao, Y., Matsuoka, K., Naganuma, M., Ogata, H., Kanai, T., and Hibi, T. (2014). Endoscopic and pathologic changes of the upper gastrointestinal tract in Crohn\u2019s disease. BioMed Res. Int., 2014.","DOI":"10.1155\/2014\/610767"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4292\/wjgpt.v10.i2.35","article-title":"Crohn\u2019s disease of esophagus, stomach and duodenum","volume":"10","author":"Pimentel","year":"2019","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3345\/cep.2021.00661","article-title":"Upper gastrointestinal tract involvement of Crohn disease: Clinical implications in children and adolescents","volume":"65","author":"Kim","year":"2022","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_107","first-page":"468","article-title":"Specific gastroduodenoscopic findings in Crohn\u2019s disease: Comparison with findings in patients with ulcerative colitis and gastroesophageal reflux disease","volume":"40","author":"Kuriyama","year":"2008","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1055\/a-1973-3796","article-title":"Small-bowel capsule endoscopy and device-assisted enteroscopy for diagnosis and treatment of small-bowel disorders: European Society of Gastrointestinal Endoscopy (ESGE) Guideline\u2014Update 2022","volume":"55","author":"Pennazio","year":"2023","journal-title":"Endoscopy"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.giec.2020.12.004","article-title":"Role of Capsule Endoscopy in Inflammatory Bowel Disease","volume":"31","author":"McCain","year":"2021","journal-title":"Gastrointest. Endosc. Clin. N. Am."},{"key":"ref_112","first-page":"148","article-title":"Clinical outcome of patients examined by capsule endoscopy for suspected small bowel Crohn\u2019s disease","volume":"39","author":"Girelli","year":"2007","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ajg.2009.713","article-title":"Capsule endoscopy has a significantly higher diagnostic yield in patients with suspected and established small-bowel Crohn\u2019s disease: A meta-analysis","volume":"105","author":"Dionisio","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/ibd\/izx107","article-title":"Comparison of Capsule Endoscopy and Magnetic Resonance Enterography for the Assessment of Small Bowel Lesions in Crohn\u2019s Disease","volume":"24","author":"Rodriguez","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_115","first-page":"279","article-title":"Capsule Endoscopy Complements Magnetic Resonance Enterography and Endoscopy in Evaluating Small Bowel Crohn\u2019s Disease","volume":"3","author":"Prichard","year":"2020","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"otaa046","DOI":"10.1093\/crocol\/otaa046","article-title":"Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn\u2019s Disease","volume":"2","author":"Calabrese","year":"2020","journal-title":"Crohn\u2019s Colitis 360"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Kharazmi, A.A., Aslani, S., Kristiansen, M.F., Dahl, E.E., and Berner-Hansen, M. (2020). Indications and diagnostic yield of small-bowel capsule endoscopy in a real-world setting. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01326-8"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/jgh.16007","article-title":"The diagnostic yield of pan-enteric capsule endoscopy in inflammatory bowel disease: A systematic review and meta-analysis","volume":"37","author":"Tamilarasan","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/ibd\/izz083","article-title":"Capsule Retention in Crohn\u2019s Disease: A Meta-analysis","volume":"26","author":"Pasha","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_120","first-page":"599","article-title":"The role of small-bowel endoscopy in inflammatory bowel disease: An updated review on the state-of-the-art in 2021","volume":"34","author":"Skamnelos","year":"2021","journal-title":"Ann. Gastroenterol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn\u2019s Disease 2016: Part 1: Diagnosis and Medical Management","volume":"11","author":"Gomollon","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Lee, S.P., Jang, H.J., Kae, S.H., Lee, J.G., and Kwon, J.H. (2022). Indication, Location of the Lesion, Diagnostic Yield, and Therapeutic Yield of Double-Balloon Enteroscopy: Seventeen Years of Experience. Diagnostics, 12.","DOI":"10.3390\/diagnostics12092224"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1007\/s00464-009-0518-z","article-title":"Use of double-balloon enteroscopy in the management of patients with Crohn\u2019s disease: Feasibility and diagnostic yield in a high-volume centre for inflammatory bowel disease","volume":"23","author":"Manes","year":"2009","journal-title":"Surg. Endosc."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gie.2014.12.039","article-title":"Double-balloon enteroscopy in Crohn\u2019s disease: Findings and impact on management in a multicenter retrospective study","volume":"82","author":"Rahman","year":"2015","journal-title":"Gastrointest. Endosc."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Singeap, A.M., Sfarti, C., Minea, H., Chiriac, S., Cuciureanu, T., Nastasa, R., Stanciu, C., and Trifan, A. (2023). Small Bowel Capsule Endoscopy and Enteroscopy: A Shoulder-to-Shoulder Race. J. Clin. Med., 12.","DOI":"10.3390\/jcm12237328"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5009\/gnl16330","article-title":"Comparison of the Efficacy and Safety of Single- versus Double-Balloon Enteroscopy Performed by Endoscopist Experts in Single-Balloon Enteroscopy: A Single-Center Experience and Meta-Analysis","volume":"11","author":"Kim","year":"2017","journal-title":"Gut Liver"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"39","DOI":"10.32074\/1591-951X-235","article-title":"Histopathology of IBD Colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD)","volume":"113","author":"Villanacci","year":"2021","journal-title":"Pathologica"},{"key":"ref_128","first-page":"511","article-title":"The histopathological approach to inflammatory bowel disease: A practice guide","volume":"464","author":"Langner","year":"2014","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_129","first-page":"262","article-title":"Histopathology of inflammatory bowel disease\u2014Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC)","volume":"52","author":"Villanacci","year":"2020","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00428-020-02982-7","article-title":"Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: Recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn\u2019s disease","volume":"478","author":"Agaimy","year":"2021","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"ref_131","first-page":"1800","article-title":"Treat to Target: The Role of Histologic Healing in Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis","volume":"19","author":"Gupta","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_132","first-page":"2518","article-title":"Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn\u2019s Disease than Endoscopic Healing","volume":"18","author":"Christensen","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.crohns.2013.06.001","article-title":"European consensus on the histopathology of inflammatory bowel disease","volume":"7","author":"Magro","year":"2013","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/gastro\/gou031","article-title":"Histological evaluation in ulcerative colitis","volume":"2","author":"DeRoche","year":"2014","journal-title":"Gastroenterol. Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1746.1991.tb01468.x","article-title":"The Sydney System: Histological division","volume":"6","author":"Price","year":"1991","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.crohns.2014.05.003","article-title":"Endoscopic biopsy samples of naive \u201ccolitides\u201d patients: Role of basal plasmacytosis","volume":"8","author":"Villanacci","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1572-0241.2000.02019.x","article-title":"Multiple organ dysfunction in ulcerative colitis","volume":"95","author":"Caprilli","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Kellermann, L., and Riis, L.B. (2021). A close view on histopathological changes in inflammatory bowel disease, a narrative review. Dig. Med. Res., 4.","DOI":"10.21037\/dmr-21-1"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/apm.12639","article-title":"Eosinophilia\u2014Associated basal plasmacytosis: An early and sensitive histologic feature of inflammatory bowel disease","volume":"125","author":"Canavese","year":"2017","journal-title":"APMIS Acta Pathol. Microbiol. Immunol. Scand."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/00365529409094843","article-title":"A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Histologic course during the 1st year after presentation","volume":"29","author":"Schumacher","year":"1994","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ibd\/izz251","article-title":"Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases","volume":"26","author":"Kim","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10151-018-1896-9","article-title":"Colonic hypereosinophilia in ulcerative colitis may help to predict the failure of steroid therapy","volume":"22","author":"Leoncini","year":"2018","journal-title":"Technol. Coloproctology"},{"key":"ref_143","first-page":"O420","article-title":"Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy","volume":"16","author":"Zezos","year":"2014","journal-title":"Color. Dis. Off. J. Assoc. Coloproctology Great Br. Irel."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/jcp.50.2.93","article-title":"Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative","volume":"50","author":"Jenkins","year":"1997","journal-title":"J. Clin. Pathol."},{"key":"ref_145","first-page":"145","article-title":"The incidence of granulomas in serial sections of rectal biopsies from patients with Crohn\u2019s disease","volume":"90","author":"Petri","year":"1982","journal-title":"Acta Pathol. Microbiol. Immunol. Scandinavica. Sect. A Pathol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/jcp.43.2.143","article-title":"Mucin depletion in inflammatory bowel disease","volume":"43","author":"McCormick","year":"1990","journal-title":"J. Clin. Pathol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2374289520937433","DOI":"10.1177\/2374289520937433","article-title":"Educational Case: Idiopathic Inflammatory Bowel Disease","volume":"7","author":"McGary","year":"2020","journal-title":"Acad. Pathol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.crohns.2013.02.020","article-title":"Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines","volume":"7","author":"Panes","year":"2013","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacr.2009.10.009","article-title":"ACR Appropriateness Criteria on Crohn\u2019s disease","volume":"7","author":"Huprich","year":"2010","journal-title":"J. Am. Coll. Radiol. JACR"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Maccioni, F., Busato, L., Valenti, A., Cardaccio, S., Longhi, A., and Catalano, C. (2023). Magnetic Resonance Imaging of the Gastrointestinal Tract: Current Role, Recent Advancements and Future Prospectives. Diagnostics, 13.","DOI":"10.3390\/diagnostics13142410"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1148\/radiol.2471070611","article-title":"Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: Meta-analysis of prospective studies","volume":"247","author":"Horsthuis","year":"2008","journal-title":"Radiology"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Alshammari, M.T., Stevenson, R., Abdul-Aema, B., Zou, G., Jairath, V., Radford, S., Marciani, L., and Moran, G.W. (2021). Diagnostic Accuracy of Non-Invasive Imaging for Detection of Colonic Inflammation in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Diagnostics, 11.","DOI":"10.3390\/diagnostics11101926"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5217\/ir.2020.00097","article-title":"Crohn\u2019s disease at radiological imaging: Focus on techniques and intestinal tract","volume":"19","author":"Cicero","year":"2021","journal-title":"Intest. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"e763","DOI":"10.1016\/j.ejrad.2012.02.011","article-title":"MR enterography correlates highly with colonoscopy and histology for both distal ileal and colonic Crohn\u2019s disease in 310 patients","volume":"81","author":"Grand","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Pasternak, G., Chrzanowski, G., Aebisher, D., Mysliwiec, A., Dynarowicz, K., Bartusik-Aebisher, D., Sosna, B., Cieslar, G., Kawczyk-Krupka, A., and Filip, R. (2023). Crohn\u2019s Disease: Basic Characteristics of the Disease, Diagnostic Methods, the Role of Biomarkers, and Analysis of Metalloproteinases: A Review. Life, 13.","DOI":"10.3390\/life13102062"},{"key":"ref_156","first-page":"354","article-title":"Small Bowel Crohn Disease at CT and MR Enterography: Imaging Atlas and Glossary of Terms","volume":"40","author":"Guglielmo","year":"2020","journal-title":"Radiogr. A Rev. Publ. Radiol. Soc. N. Am. Inc."},{"key":"ref_157","first-page":"367","article-title":"MR enterographic manifestations of small bowel Crohn disease","volume":"30","author":"Tolan","year":"2010","journal-title":"Radiogr. A Rev. Publ. Radiol. Soc. N. Am. Inc."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/17474124.2023.2274926","article-title":"Small bowel imaging in inflammatory bowel disease: Updates for 2023","volume":"17","author":"Hameed","year":"2023","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"110846","DOI":"10.1016\/j.ejrad.2023.110846","article-title":"PET\/MR enterography in inflammatory bowel disease: A review of applications and technical considerations","volume":"163","author":"Borhani","year":"2023","journal-title":"Eur. J. Radiol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Yoon, K., Chang, K.-T., and Lee, H.J. (2015). MRI for Crohn\u2019s Disease: Present and Future. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/786802"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"AV146","DOI":"10.1667\/RRAV12.1","article-title":"Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950\u20131997","volume":"178","author":"Preston","year":"2012","journal-title":"Radiat. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ibd.21533","article-title":"Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn\u2019s disease","volume":"17","author":"Fiorino","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s43055-021-00506-0","article-title":"Diagnostic role of computed tomography enterography (CTE) in assessment of intra-mural and extra-intestinal CT findings in active Crohn\u2019s disease (CD)","volume":"52","author":"Ali","year":"2021","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1136\/flgastro-2022-102117","article-title":"Imaging in inflammatory bowel disease: Current and future perspectives","volume":"13","author":"Shaban","year":"2022","journal-title":"Frontline Gastroenterol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2468-1253(18)30161-4","article-title":"Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn\u2019s disease (METRIC): A multicentre trial","volume":"3","author":"Taylor","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wei, L., Ge, W.-S., Duan, Y.-R., Ding, W.-J., Lu, X.-Y., Huang, Y.-L., Chen, S., Dong, Y., and Du, P. (2024). Application of Dynamic Contrast-Enhanced Ultrasound in Evaluation the Activity of Crohn\u2019s Disease. Diagnostics, 14.","DOI":"10.3390\/diagnostics14070672"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"17562848211016259","DOI":"10.1177\/17562848211016259","article-title":"Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn\u2019s disease","volume":"14","author":"Ma","year":"2021","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/flgastro-2021-102065","article-title":"Ultrasound use to assess Crohn\u2019s disease in the UK: A survey of British Society of Gastroenterology Inflammatory Bowel Disease Group members","volume":"13","author":"Radford","year":"2022","journal-title":"Frontline Gastroenterol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"e12694","DOI":"10.1111\/sji.12694","article-title":"The oncostatin M-stromal cell axis in health and disease","volume":"88","author":"West","year":"2018","journal-title":"Scand. J. Immunol."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Wolf, C.L., Pruett, C., Lighter, D., and Jorcyk, C.L. (2023). The clinical relevance of OSM in inflammatory diseases: A comprehensive review. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1239732"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/14728222.2019.1677608","article-title":"Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)","volume":"23","author":"Verstockt","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm.4307","article-title":"Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease","volume":"23","author":"West","year":"2017","journal-title":"Nat. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/ibd\/izab032","article-title":"Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease","volume":"27","author":"Verstockt","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4240\/wjgs.v16.i1.228","article-title":"Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis","volume":"16","author":"Yang","year":"2024","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/cbin.10258","article-title":"Alphavbeta6 is required in maintaining the intestinal epithelial barrier function","volume":"38","author":"Yu","year":"2014","journal-title":"Cell Biol. Int."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1177\/41.10.8245410","article-title":"Restricted distribution of integrin beta 6 mRNA in primate epithelial tissues","volume":"41","author":"Breuss","year":"1993","journal-title":"J. Histochem. Cytochem. Off. J. Histochem. Soc."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1053\/j.gastro.2021.02.019","article-title":"Identification of an Anti-Integrin alphavbeta6 Autoantibody in Patients with Ulcerative Colitis","volume":"160","author":"Kuwada","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Rydell, N., Ekoff, H., Hellstrom, P.M., and Moverare, R. (2022). Measurement of Serum IgG Anti-Integrin alphavbeta6 Autoantibodies Is a Promising Tool in the Diagnosis of Ulcerative Colitis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071881"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.gastro.2022.12.042","article-title":"Anti-Integrin alphavbeta6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis","volume":"164","author":"Livanos","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cell.2010.11.008","article-title":"Glycomics hits the big time","volume":"143","author":"Hart","year":"2010","journal-title":"Cell"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.bbagen.2019.07.001","article-title":"Inflammatory bowel disease\u2014Glycomics perspective","volume":"1863","author":"Hanic","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrgastro.2014.78","article-title":"The role of glycosylation in IBD","volume":"11","author":"Theodoratou","year":"2014","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1021\/acs.jproteome.3c00260","article-title":"Immunoglobulin A Glycosylation Differs between Crohn\u2019s Disease and Ulcerative Colitis","volume":"22","author":"Clerc","year":"2023","journal-title":"J. Proteome Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/ecco-jcc\/jjad012","article-title":"Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease","volume":"17","author":"Shubhakar","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1146\/annurev-biochem-060815-014442","article-title":"Reactive Oxygen Species and Neutrophil Function","volume":"85","author":"Winterbourn","year":"2016","journal-title":"Annu. Rev. Biochem."},{"key":"ref_186","first-page":"e1004","article-title":"Fecal Myeloperoxidase as a Biomarker for Inflammatory Bowel Disease","volume":"9","author":"Hansberry","year":"2017","journal-title":"Cureus"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/ecco-jcc\/jjac098","article-title":"Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease","volume":"16","author":"Swaminathan","year":"2022","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Swaminathan, A., Borichevsky, G.M., Frampton, C.M., Day, A.S., Hampton, M.B., Kettle, A.J., and Gearry, R.B. (2024). Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease. Inflamm. Bowel Dis., izae032.","DOI":"10.1093\/ibd\/izae032"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.3748\/wjg.v20.i12.3223","article-title":"Trefoil factors in inflammatory bowel disease","volume":"20","author":"Aamann","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_190","first-page":"788","article-title":"Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis","volume":"23","author":"Nakov","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15403\/jgld-177","article-title":"Trefoil Factor 3 is Highly Predictive of Complete Mucosal Healing Independently and in Combination with C-Reactive Protein in Patients with Ulcerative Colitis","volume":"28","author":"Nakov","year":"2019","journal-title":"J. Gastrointest. Liver Dis. JGLD"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41390-020-0812-y","article-title":"Evaluation of inflammatory bowel disease activity in children using serum trefoil factor peptide","volume":"88","author":"Teng","year":"2020","journal-title":"Pediatr. Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3748\/wjg.v23.i1.135","article-title":"Trefoil factor-3 is not a useful marker of mucosal healing in Crohn\u2019s disease treated with anti-TNF-alpha antibodies","volume":"23","author":"Eder","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/13497413.2018.1481582","article-title":"LRG is a novel inflammatory marker clinically useful for the evaluation of disease activity in rheumatoid arthritis and inflammatory bowel disease","volume":"41","author":"Naka","year":"2018","journal-title":"Immunol. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1038\/s41598-021-90441-x","article-title":"Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease","volume":"11","author":"Yasutomi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ecco-jcc\/jjw132","article-title":"Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis","volume":"11","author":"Shinzaki","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41420-023-01455-5","article-title":"Serum amyloid protein A in inflammatory bowel disease: From bench to bedside","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Bourgonje, A.R., von Martels, J.Z.H., Gabriels, R.Y., Blokzijl, T., Buist-Homan, M., Heegsma, J., Jansen, B.H., van Dullemen, H.M., Festen, E.A.M., and Ter Steege, R.W.F. (2019). A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease. Front. Med., 6.","DOI":"10.3389\/fmed.2019.00251"},{"key":"ref_199","first-page":"553","article-title":"Serum amyloid A level correlated with endoscopic findings in patients with Crohn\u2019s disease-Possible biomarker for evaluating mucosal healing","volume":"50","author":"Ishihara","year":"2018","journal-title":"Dig. Liver Dis. Off. J. Ital. Soc. Gastroenterol. Ital. Assoc. Study Liver"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Wakai, M., Hayashi, R., Tanaka, S., Naito, T., Kumada, J., Nomura, M., Takigawa, H., Oka, S., Ueno, Y., and Ito, M. (2020). Serum amyloid A is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01229-8"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/annrheumdis-2014-205216","article-title":"Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: A population-based cohort study","volume":"74","author":"Kim","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/ibd\/izz319","article-title":"Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease","volume":"26","author":"Afonso","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/MIB.0000000000000062","article-title":"Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis","volume":"20","author":"Arai","year":"2014","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/jgh.15782","article-title":"Prostaglandin E-major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase","volume":"37","author":"Sakurai","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1189\/jlb.0706426","article-title":"The melanocortin system in leukocyte biology","volume":"81","author":"Catania","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/med.10064","article-title":"Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies","volume":"24","author":"Holder","year":"2004","journal-title":"Med. Res. Rev."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Gravina, A.G., Pellegrino, R., Durante, T., Palladino, G., Imperio, G., D\u2019Amico, G., Trotta, M.C., Dallio, M., Romeo, M., and D\u2019Amico, M. (2023). The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials. Cells, 12.","DOI":"10.3390\/cells12141889"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2007-0027","article-title":"Alpha-melanocyte-stimulating hormone and related tripeptides: Biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases","volume":"29","author":"Brzoska","year":"2008","journal-title":"Endocr. Rev."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/gut.2005.083634","article-title":"Crucial role of the melanocortin receptor MC1R in experimental colitis","volume":"55","author":"Maaser","year":"2006","journal-title":"Gut"},{"key":"ref_210","first-page":"1975","article-title":"Lactobacillus casei secreting alpha-MSH induces the therapeutic effect on DSS-induced acute colitis in Balb\/c Mice","volume":"18","author":"Yoon","year":"2008","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Spana, C., Taylor, A.W., Yee, D.G., Makhlina, M., Yang, W., and Dodd, J. (2018). Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01535"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Dodd, J., Jordan, R., Makhlina, M., Barnett, K., Roffel, A., Spana, C., Obr, A., Dhingra, P., and Kayne, P.S. (2023). A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1083333"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/php.12620","article-title":"The Effects of Ultraviolet Eye Irradiation on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice","volume":"92","author":"Hiramoto","year":"2016","journal-title":"Photochem. Photobiol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1189\/jlb.0306175","article-title":"MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct","volume":"76","author":"Getting","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/bj3310211","article-title":"Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak\/STAT pathway","volume":"331","author":"Buggy","year":"1998","journal-title":"Biochem. J."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3748\/wjg.v30.i9.1132","article-title":"Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity?","volume":"30","author":"Gravina","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.3748\/wjg.v27.i36.6142","article-title":"Urotensin II levels in patients with inflammatory bowel disease","volume":"27","author":"Alicic","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2174\/0929867043455495","article-title":"Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictor","volume":"11","author":"Grieco","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1530\/JOE-18-0505","article-title":"Urotensin II: An inflammatory cytokine","volume":"240","author":"Sun","year":"2019","journal-title":"J. Endocrinol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.23736\/S1121-421X.19.02602-3","article-title":"Urotensin II receptor expression in patients with ulcerative colitis: A pilot study","volume":"66","author":"Gravina","year":"2020","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"e13972","DOI":"10.1111\/eci.13972","article-title":"The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis","volume":"53","author":"Gravina","year":"2023","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1513\/pats.200510-109JH","article-title":"The aquaporin water channels","volume":"3","author":"Agre","year":"2006","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1242\/jcs.02519","article-title":"More than just water channels: Unexpected cellular roles of aquaporins","volume":"118","author":"Verkman","year":"2005","journal-title":"J. Cell Sci."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/CEG.S70119","article-title":"Reduced expression of aquaporins in human intestinal mucosa in early stage inflammatory bowel disease","volume":"8","author":"Ricanek","year":"2015","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00441-004-0932-4","article-title":"Aquaporin expression is downregulated in a murine model of colitis and in patients with ulcerative colitis, Crohn\u2019s disease and infectious colitis","volume":"318","author":"Hardin","year":"2004","journal-title":"Cell Tissue Res."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/gmic.1.1.11036","article-title":"Infectious diarrhea: Cellular and molecular mechanisms","volume":"1","author":"Hodges","year":"2010","journal-title":"Gut Microbes"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.tim.2008.08.004","article-title":"Subcellular alterations that lead to diarrhea during bacterial pathogenesis","volume":"16","author":"Guttman","year":"2008","journal-title":"Trends Microbiol."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Guo, X., Huang, C., Xu, J., Xu, H., Liu, L., Zhao, H., Wang, J., Huang, W., Peng, W., and Chen, Y. (2021). Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.818902"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijmm.2014.02.009","article-title":"Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes","volume":"304","author":"Busquets","year":"2014","journal-title":"Int. J. Med. Microbiol. IJMM"},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Olbjorn, C., Smastuen, M.C., and Moen, A.E.F. (2022). Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease. Microorganisms, 10.","DOI":"10.3390\/microorganisms10071273"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Xu, Z.Z., He, Y., Yang, Y., Liu, L., Lin, Q., Nie, Y., Li, M., Zhi, F., and Liu, S. (2018). Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction. mSystems, 3.","DOI":"10.1128\/mSystems.00188-17"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ibd\/izab059","article-title":"Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission","volume":"27","author":"Iacucci","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3748\/wjg.v21.i7.2108","article-title":"Endocytoscopic narrow-band imaging efficiency for evaluation of inflammatory activity in ulcerative colitis","volume":"21","author":"Maeda","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0043-106556","article-title":"Endocytoscopy can be used to assess histological healing in ulcerative colitis","volume":"49","author":"Nakazato","year":"2017","journal-title":"Endoscopy"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"e0107","DOI":"10.1097\/MD.0000000000010107","article-title":"Endocytoscopic classification can be predictive for relapse in ulcerative colitis","volume":"97","author":"Ueda","year":"2018","journal-title":"Medicine"},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Chiriac, S., Sfarti, C.V., Minea, H., Stanciu, C., Cojocariu, C., Singeap, A.M., Girleanu, I., Cuciureanu, T., Petrea, O., and Huiban, L. (2023). Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy-A New Potential Therapeutic Target in Inflammatory Bowel Disease. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071230"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/ajg.2009.664","article-title":"Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy","volume":"105","author":"Li","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2022.10.014","article-title":"Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial","volume":"164","author":"Rath","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3748\/wjg.v24.i10.1167","article-title":"Colonic lesion characterization in inflammatory bowel disease: A systematic review and meta-analysis","volume":"24","author":"Lord","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2007.01.048","article-title":"Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis","volume":"132","author":"Kiesslich","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/s41598-017-02606-2","article-title":"Classification of Paediatric Inflammatory Bowel Disease using Machine Learning","volume":"7","author":"Mossotto","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Tong, Y., Lu, K., Yang, Y., Li, J., Lin, Y., Wu, D., Yang, A., Li, Y., Yu, S., and Qian, J. (2020). Can natural language processing help differentiate inflammatory intestinal diseases in China? Models applying random forest and convolutional neural network approaches. BMC Med. Inform. Decis. Mak., 20.","DOI":"10.1186\/s12911-020-01277-w"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"G328","DOI":"10.1152\/ajpgi.00360.2020","article-title":"Gut microbiome-based supervised machine learning for clinical diagnosis of inflammatory bowel diseases","volume":"320","author":"Manandhar","year":"2021","journal-title":"Am. J. Physiology. Gastrointest. Liver Physiol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ibd\/izx066","article-title":"Disagreement Among Gastroenterologists Using the Mayo and Rutgeerts Endoscopic Scores","volume":"24","author":"Fernandes","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.gie.2018.10.020","article-title":"Novel computer-assisted diagnosis system for endoscopic disease activity in patients with ulcerative colitis","volume":"89","author":"Ozawa","year":"2019","journal-title":"Gastrointest. Endosc."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.gie.2019.11.012","article-title":"Deep learning algorithms for automated detection of Crohn\u2019s disease ulcers by video capsule endoscopy","volume":"91","author":"Klang","year":"2020","journal-title":"Gastrointest. Endosc."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ecco-jcc\/jjaa234","article-title":"Automated Detection of Crohn\u2019s Disease Intestinal Strictures on Capsule Endoscopy Images Using Deep Neural Networks","volume":"15","author":"Klang","year":"2021","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_248","first-page":"585","article-title":"Clinical usefulness of a deep learning-based system as the first screening on small-bowel capsule endoscopy reading","volume":"32","author":"Aoki","year":"2020","journal-title":"Dig. Endosc. Off. J. Jpn. Gastroenterol. Endosc. Soc."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3748\/wjg.v29.i3.508","article-title":"Artificial intelligence and inflammatory bowel disease: Where are we going?","volume":"29","author":"Spadaccini","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1136\/gutjnl-2021-326376","article-title":"PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: Development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system","volume":"71","author":"Gui","year":"2022","journal-title":"Gut"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"2300670","DOI":"10.1080\/07853890.2023.2300670","article-title":"Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: A perspective and expert opinion","volume":"55","author":"Pinton","year":"2023","journal-title":"Ann. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1384\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:07:28Z","timestamp":1760108848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/13\/1384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":251,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["diagnostics14131384"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14131384","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}